Hemoglobin-albumin Crosslinked Copolymers: Reduced Prooxidant Reactivity

REFERENCES

• Alayash, A.I. (1999). Hemoglobin-based blood substitutes: Oxygen carriers, pressor agents, or oxidants? Nature Biotech, 17: 545–549.
   PubMed Web of Science ®Google Scholar
• Alayash, A.I. (2000). Hemoglobin-based blood substitutes and the hazards of blood radicals. Free Radic. Res, 33: 341–348.
   PubMed Web of Science ®Google Scholar
• Alayash, A.I. (2004). Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov, 3: 152–9.
   PubMed Web of Science ®Google Scholar
• Deac, F., Todea, A. and Silaghi-Dumitrescu, R. (2009). Metal Elements in Environment, Medicine and Biology Tome IX, Silaghi-Dumitrescu, R. Garban, G. (Cluj University Press, Cluj-Napoca, Romania), 165–173.
   Google Scholar
• Deac, F., Iacob, B., Fischer-Fodor, E., Damian, G. and Silaghi-Dumitrescu, R. (2010). Derivatization of hemoglobin with periodate-generated reticulation agents: evaluation of oxidative reactivity for potential blood substitutes. J Biochem (Tokyo), in press.
   PubMed Web of Science ®Google Scholar
• Eike, J.H. and Palmer, A.F. (2004). Effect of Cl- and H+ on the oxygen binding properties of glutaraldehyde-polymerized bovine hemoglobin-based blood substitutes. Biotechnol Prog, 20: 1543–9.
   PubMed Web of Science ®Google Scholar
• Eike, J.H. and Palmer, A.F. (2004). Effect of glutaraldehyde concentration on the physical properties of polymerized hemoglobin-based oxygen carriers. Biotechnol Prog, 20: 1225–32.
   PubMed Web of Science ®Google Scholar
• Eike, J.H. and Palmer, A.F. (2004). Oxidized mono-, di-, tri-, and polysaccharides as potential hemoglobin cross-linking reagents for the synthesis of high oxygen affinity artificial blood substitutes. Biotechnol Prog, 20: 953–62.
   PubMed Web of Science ®Google Scholar
• Eike, J.H. and Palmer, A.F. (2004). Effect of NaBH4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin. Biotechnol Prog, 20: 946–52.
   PubMed Web of Science ®Google Scholar
• Dunne, J., Svistunenko, D.A., Alayash, A.I., Wilson, M.T. and Cooper, C.E. (1999). Reactions of cross-linked methaemoglobins with hydrogen peroxide. Adv Exp Med Biol, 471: 9–15.
   PubMed Web of Science ®Google Scholar
• Dunne, J., Caron, A., Menu, P., Alayash, A.I., Buehler, P.W., Wilson, M.T., Silaghi-Dumitrescu, R., Faivre, B. and Cooper, C.E. (2006). Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo. Biochem J, 399: 513–24.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (2009). Nanobiotechnology for hemoglobin based blood substitutes. Crit Care Clinics, 25: 373–382.
   PubMed Web of Science ®Google Scholar
• Chang, T.M. (2004). Hemoglobin-based red blood cell substitutes. Artif Organs, 28: 789–94.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials (Karger Landes, Basel).
   Google Scholar
• D’Agnillo, F. and Chang, T.M. (1998). Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol, 16: 667–71.
   PubMed Web of Science ®Google Scholar
• D’Agnillo, F. Chang, T.M.S. (1998). Polyhemoglobin superoxide dismutase catalase as a blood substitute with antioxidant properties. Nat. Biotechnol, 16: 667–671.
   PubMed Web of Science ®Google Scholar
• Chang, T.M., D’Agnillo, F., Yu, W.P. and Razack, S. (2000). Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation. Adv Drug Deliv Rev, 40: 213–8.
   PubMed Web of Science ®Google Scholar
• Antonini, E. and Brunori, M. (1971). Hemoglobin and Myoglobin in their Reaction with Ligands (North-Holland, Amsterdam).
   Google Scholar
• Ibrahim, M.A., El-Gohary, M.I., Saleh, N.A and Elashry, M.Y. (2008). Spectroscopic study on oxidative reactions of normal and pathogenic hemoglobin molecules. Rom. J. Biophys, 18: 39–47.
   Google Scholar
• Reeder, B.J., Svistunenko, D.A., Cooper, C.E. and Wilson, M.T. (2004). The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology. Antioxid. Redox Sign, 6: 954–966.
   PubMed Web of Science ®Google Scholar
• Reeder, B.J., Grey, M., Silaghi-Dumitrescu, R.L., Svistunenko, D.A., Bulow, L., Cooper, C.E. and Wilson, M.T. (2008). Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes. J Biol Chem, 283: 30780–7.
   PubMed Web of Science ®Google Scholar
• Silaghi-Dumitrescu, R., Reeder, B.J., Nicholls, P., Cooper, C.E. and Wilson, M.T. (2007). Ferryl haem protonation gates peroxidatic reactivity in globins. Biochem J, 403: 391–5.
   PubMed Web of Science ®Google Scholar
• Fedorov, A.N., Iarochkin, V.S., Koziner, V.B., Hachaturian, A.A. and Rozenberg, G.I. (1978). Support of respiration and hemodynamics by complete blood replacement with artificial oxygen carriers: polyhemoglobinalbumin and polyhemoglobin. Dokl Akad Nauk SSSR, 243: 1324–6.
   PubMedGoogle Scholar